Sign in
CompletedNo phase

Hypofractionated Brain Radiationcavity

Key facts

Who runs it
Oncology Institute of Southern Switzerland
Where
Switzerland6 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
56 people enrolled
Started
Jan 2015
Ended
18 Jun 2024
Type of study
Interventional, 2 groups
Treatments tested
  • IGRT
  • SRS
Record updated
17 July 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Patient underwent surgery for single brain metastasis arising from solid neoplasia (lung, breast, melanoma, kidney, colorectal), with initial histological diagnosis, or selected cases with a resected lesion and a further non-resected lesion (from 1 to 2 lesions), treatable with SRS / IGRT of the surgical cavity
  • Patient ≥ 18 years
  • Willngness to participate in the study, written informed consent
  • Performance Status according to WHO 0-I
  • Good general conditions and organ function
  • Newly diagnosed chemotherapy-naïve disease or controlled systemic disease
  • Good bone marrow, renal and hepatic function
  • Stable steroid dose or reduced for at least 5 days

Who cannot take part

  • History of previous brain irradiation
  • Histological diagnosis other than lung, breast, melanoma, kidney and colorectal malignancy
  • Pregnancy or breastfeeding

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Stereotactic radiosurgery or hypofractionated radiotherapy of the resection cavity after metastasectomy in cancer patients with brain metastases

The 2 groups in the trial

  • IGRTTreatment being tested

    Image-Guided Hypofractionated Stereotactic Radiation Therapy (IGRT) of the resection cavity

  • SRSTreatment being tested

    Stereotactic Radiosurgery of the resection cavity (SRS)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Stereotactic Radiosurgery or Hypofractionated Image-Guided Radiotherapy to the Surgical Cavity After Resection of Brain Metastases: a Multicenter, Single Arm, Open-label, Phase II Trial
Record updated
17 July 2024